Chitosan Capsules Using Phytic Acid Cross-Linking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing chitosan capsules face challenges with low encapsulation yield, stability in acidic conditions, and controlled release of active ingredients, limiting their application in pharmaceutical, food, and cosmetic fields due to the use of toxic cross-linking agents and complex manufacturing processes.
Innovation Solution
A chitosan capsule is developed using phytic acid as a low-toxicity cross-linking agent, which forms a stable matrix with chitosan through ionic gelation, enabling high encapsulation efficiency and pH-dependent sustained release of active ingredients, protecting them from acidic conditions and ensuring effective delivery in the intestine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional cross-linking agents (glutaraldehyde, sulfuric acid) are used to form chitosan capsules, then the capsule formation speed and cross-linking efficiency are improved, but the toxicity increases and limits application in food and cosmetic fields
Solution Approach 1:
The patent replaces toxic cross-linking agents with phytic acid, which is naturally occurring and non-toxic. This substitution maintains capsule formation efficiency while eliminating the harmful effects that limit application in food and cosmetic fields, effectively using a benign, short-lived cross-linking mechanism.
Solution Approach 2:
Phytic acid acts as an intermediary cross-linking agent between chitosan molecules, forming a stable gel structure without requiring toxic chemicals. The phytic acid mediates the cross-linking process through its multiple phosphate groups that bind to chitosan's amino groups, achieving both productivity and safety.
2Speed
If chitosan capsules are designed for rapid release, then the delivery speed is improved, but the stability in acidic stomach conditions deteriorates
Solution Approach 1:
The patent creates local quality differentiation in the capsule structure through pH-responsive behavior. The chitosan-phytic acid gel matrix remains stable in acidic stomach conditions (protecting the payload) but undergoes structural changes in the more neutral intestinal environment, enabling controlled release at the target location with both stability and delivery speed.
Solution Approach 2:
The capsule utilizes parameter changes in pH to control its release behavior. The chitosan-phytic acid complex exhibits different structural properties at different pH levels, remaining intact in acidic conditions and releasing the active ingredient in neutral/alkaline intestinal conditions, thus achieving both stability and rapid delivery when needed.
3Reliability
If the capsule membrane thickness is increased to improve protection, then the stability in acidic conditions is improved, but the release rate of active ingredient deteriorates
Solution Approach 1:
The patent employs a dynamic capsule membrane structure made of chitosan-phytic acid gel that can change its properties in response to environmental pH changes. The gel matrix provides robust protection when thick but can dynamically adjust its mesh size and permeability in response to pH changes, allowing controlled release rates without compromising protection stability.
4Loss of time
If ionic gelation method is used to form capsules quickly, then the manufacturing time is reduced, but the encapsulation yield and controlled release performance deteriorate
Solution Approach 1:
The patent uses a composite chitosan-phytic acid gel system that combines the advantages of rapid ionic gelation with improved encapsulation performance. The specific interaction between chitosan and phytic acid creates a gel matrix that forms quickly while maintaining high encapsulation yield and controlled release properties, resolving the trade-off between speed and precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The chitosan-phytic acid capsule achieves high encapsulation efficiency, maintains stability under acidic conditions, and exhibits a sustained release mechanism, enhancing the bioavailability of active ingredients and expanding its applications across various industrial fields.
Implementation Method 1
ionic gelation reaction of chitosan as a biodegradable polymer with phytic acid capable of rapidly and effectively forming a cross-linking reaction with the chitosan polymer
Implementation Method 2
exhibiting a sustained-release mechanism which implies appropriate slow release of the active ingredient over a long period
Data Source
AI summary
The present invention relates to a chitosan capsule in which a soluble active ingredient is encapsulated in a matrix containing chitosan and phytic acid; a cross-linking method and materials capable of being used in preparing the capsule; and pharmaceutical, food and cosmetic compositions comprising the capsule. The chitosan capsule according to the present invention is prepared via ionic gelation of chitosan as a biodegradable polymer with phytic acid capable of rapidly and effectively forming a cross-linking reaction with the chitosan polymer. The capsule of the present invention shows high encapsulation efficiency for a soluble active ingredient and protects the soluble active ingredient from being damaged in a digestive tract, resulting in improving an in vivo delivery efficiency of a physiologically active material. Further, since the capsule of the present invention has a pH-dependent sustained-release mechanism which can minimize the release of a soluble active ingredient in the stomach and gradually release in the intestine, it is possible to regulate sustained-release of a soluble active ingredient.